10 web-programmer-developer-"https:"-"UCL"-"U.S"-"https:" research jobs at University of Nebraska Medical Center in United States
-
adenocarcinoma (PDA) pathogenesis. The murine models of distinct genetic subtypes of pancreas cancer that we have developed form the basis of our integrated, systematic, and multidisciplinary research program. Our
-
/2025 Position Qualification Position Summary The Department of Environmental, Agricultural and Occupational Health (EAOH) and the Water, Climate and Health (WCH) Program in the College of Public Health
-
investigates molecular and cellular mechanisms of pancreatic ductal adenocarcinoma (PDA) pathogenesis. The murine models of distinct genetic subtypes of pancreas cancer that we have developed form the basis
-
adenocarcinoma (PDA) pathogenesis. The murine models of distinct genetic subtypes of pancreas cancer that we have developed form the basis of our integrated, systematic, and multidisciplinary research program. Our
-
Associate to join our lymphoma research program. The successful candidate will work at the interface of cancer biology, functional genomics, and translational research, with a focus on understanding the
-
to understand tumor microenvironment, discover novel targets, and develop therapeutic strategies for targeting aggressive brain metastatic cancers, including breast, non-small, and small cell lung cancers
-
. To accelerate established efforts, team requires the candidate to partner with on-site scientists with virological, animal model and neuroscience expertise. The program was the first to develop a novel humanized
-
of a career. Designs, evaluates experiments and interprets data. Develops new ideas that promote current research. Prepares and publishes scientific manuscripts under the direction of the Principal
-
of current assays and the development of new therapeutics based on nanotechnology. Required Qualifications Ph.D. in Biology, cell biology, pharmaceutical sciences or related field. Supplemental Qualifications
-
, bioinformatics, in vitro and in vivo experiments to evaluate the combination drug therapy in glioblastoma and the development of biomarkers for pseudoprogression. He/she will be also involved in animal genotyping